Outcome of Primary Hyperoxaluria Type 3: Clinics, Diagnostics, and Follow-Up
Cristina Martín-Higueras(Universidad de La Laguna), Bernd Höppe(University of Bonn), Marcin Zaniew(University of Zielona Góra), Przemysław Sikora(Medical University of Lublin), Bodo B. Beck(University of Cologne), Sander F. Garrelfs(Emma Kinderziekenhuis)
Cited by 0
Related Papers
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4
|Nature Genetics|2006|573
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|505
History, epidemiology and regional diversities of urolithiasis
|Pediatric Nephrology|2008|460
The primary hyperoxalurias
|Kidney International|2009|373
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361